16 Hour MAT Waiver Course for PAs 2020

Target Audience: 

This activity will assist physician assistants (PAs) who wish to apply for a waiver to prescribe buprenorphine for the treatment of opioid use disorders.  

In accordance with the Comprehensive Addiction and Recovery Act (CARA), PAs must complete 24 hours of specialized training to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder. This activity will allow PAs to fulfill the 16 hour portion of the 24 hour MAT waiver training requirement.

Educational Objectives:

At the conclusion of this activity, learners should be able to:

  • Provide information about the pharmacology and clinical use of buprenorphine
  • Provide information on other approved antagonist and agonist medications to treat opioid use disorder
  • Provide resources needed to set up office-based treatment of opioid use disorder using buprenorphine  

FeeNo cost 

image

Joint Accreditation Statement:  In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

image

AAPA Credit Designation Statement Enduring Material: American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 16 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 

Method of participation in the activity: To be awarded a maximum of 16 AAPA Category 1 CME credits and a Certificate of Completion you must:

  • Review 16 training modules (16 hours) provided in this activity.
  • Earn a passing score of 75% on each of the module’s post-tests.
  • Complete a final evaluation and follow instructions at the end of the course regarding how to retrieve your Certificate of Completion as well as your continuing credit certificate*.

*Credit will not be awarded unless all components of the program are completed. Partial credit will not be awarded.

DisclosuresAAAP's CME program aims to provide educational information that is balanced, independent, objective and free of bias and based on evidence. In order to resolve any identified Conflicts of Interest, disclosure information from all series planners and speakers is provided during the planning process to ensure resolution of any identified conflicts. The following PCSS AAAP staff and CPD Committee members have reported that they have no commercial relationships relevant to the content of this activity to disclose: Dean Krahn, MD, Michael Goedde, MD, Thomas Penders, MD, Alan Gordon, MD, Oliveria Bugunovic, MD, Margi Kotz, MD, Kathryn Cates-Wessel, Justina Pereira, Erin Waters, Seth Acton, Sherly Charles, Sharon Joubert-Frezza and Miriam Giles. Kevin Sevarino, MD owns a small amount of stock in GSK. PCSS Content Developers for this 16 hour course disclose the following: https://30qkon2g8eif8wrj03zeh0...

Disclosure of Unlabeled Medication Use: Faculty have been advised that any recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. AAAP has determined that all scientific research referred to, reported, or used in this course conforms to the generally accepted standards of experimental design, data collection, and analysis.  

Support for the Program:

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


Key:

Complete
Failed
Available
Locked
Consent to Release Information
1 Question
1 Question Permission to Release Information Regarding Completion of Course to Center for Substance Abuse Treatment (CSAT)
Module 1: Overview of Substance Use Disorders
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 1?
Agree to terms to continue.
Agree to terms to continue.
Module 1 Post-test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 2: Changing Language to Change Care - Stigma and Substance Use Disorders
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 2?
Agree to terms to continue.
Agree to terms to continue.
Module 2 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 3: Screening, Assessment and Treatment Initiation for SUD
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 3?
Agree to terms to continue.
Agree to terms to continue.
Module 3 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 4: Medication for Opioid Use Disorder
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 4?
Agree to terms to continue.
Agree to terms to continue.
Module 4 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 5: Integrating Opioid Use Disorder Treatment in Clinical Care
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 5?
Agree to terms to continue.
Agree to terms to continue.
Module 5 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 6: Standard Medical Management for Opioid Use Disorder in Primary Care
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 6?
Agree to terms to continue.
Agree to terms to continue.
Module 6 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 7: Principles of Motivational Interviewing: Useful for Primary Care Physicians
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 7?
Agree to terms to continue.
Agree to terms to continue.
Module 7 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 8: Opioids for Pain - Understanding and Mitigating Risks
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 8?
Agree to terms to continue.
Agree to terms to continue.
Module 8 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 9: Lab Testing in Assessment of Substance Use Disorders
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 9?
Agree to terms to continue.
Agree to terms to continue.
Module 9 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 10: Regulatory Issues and Medicated-Assisted Treatment
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 10?
Agree to terms to continue.
Agree to terms to continue.
Module 10 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 11: Medical Considerations for Patients with Opioid Use Disorder
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 11?
Agree to terms to continue.
Agree to terms to continue.
Module 11 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 12: Management of Other Substance Use Disorders - Benzodiazepines, Cocaine and Other Stimulants, Cannabis
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 12?
Agree to terms to continue.
Agree to terms to continue.
Module 12 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 13: Adolescent Substance Use
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 13?
Agree to terms to continue.
Agree to terms to continue.
Module 13 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 14: Substance Use Disorders in Older People
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 14?
Agree to terms to continue.
Agree to terms to continue.
Module 14 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 15: Treating Women for Opioid Use Disorder during Pregnancy - Clinical Challenges
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 15?
Agree to terms to continue.
Agree to terms to continue.
Module 15 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Module 16: Preventing Overdose with Education and Naloxone Rescue Kits
Open to view video.
Open to view video.
Do you attest that you have viewed the entirety of Module 16?
Agree to terms to continue.
Agree to terms to continue.
Module 16 Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
GPRA Survey
NOTE: This component must be completed to obtain your certificate of completion. The Government Performance and Results Modernization Act of 2010 updated some aspects of the Government Performance and Results Act (GPRA) of 1993. Federal agencies are required to set long-term goals and objectives as well as specific near-term performance goals. As part of this federal mandate, all SAMHSA grantees are required to collect and report performance data using approved measurement tools
Certificate of Completion
Please fill out your information via the link below to end this course and obtain your Certificate of Completion. Note: upon completion of this step, you will receive your certificate of completion via email. Please be sure to check your spam folder for this certificate.